New York Life Investment Management LLC Has $65.42 Million Position in NYLI U.S. Large Cap R&D Leaders ETF $LRND

New York Life Investment Management LLC increased its stake in shares of NYLI U.S. Large Cap R&D Leaders ETF (NASDAQ:LRND) by 744.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,604,816 shares of the company’s stock after buying an additional 1,414,816 shares during the quarter. New York Life Investment Management LLC owned about 50.15% of NYLI U.S. Large Cap R&D Leaders ETF worth $65,420,000 at the end of the most recent reporting period.

NYLI U.S. Large Cap R&D Leaders ETF Price Performance

Shares of NASDAQ:LRND opened at $45.02 on Friday. The company has a market capitalization of $306.14 million, a P/E ratio of 23.74 and a beta of 1.09. NYLI U.S. Large Cap R&D Leaders ETF has a 1 year low of $33.12 and a 1 year high of $45.02. The business’s 50 day simple moving average is $40.03 and its 200 day simple moving average is $40.32.

NYLI U.S. Large Cap R&D Leaders ETF Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, April 2nd. Investors of record on Tuesday, March 31st were given a dividend of $0.0383 per share. This is an increase from NYLI U.S. Large Cap R&D Leaders ETF’s previous quarterly dividend of $0.02. This represents a $0.15 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend was Tuesday, March 31st.

About NYLI U.S. Large Cap R&D Leaders ETF

The IQ U.S. Large Cap R&D Leaders ETF (LRND) is an exchange-traded fund that is based on the IQ U.S. Large Cap R&D Leaders index. The fund tracks an index of 100 large-cap US companies selected and weighted based on the most recently reported one year research and development (R&D) spending. LRND was launched on Feb 8, 2022 and is managed by IndexIQ.